IL-17a Promotes Hepatocellular Carcinoma by Increasing FAP Expression in Hepatic Stellate Cells via Activation of the STAT3 Signaling Pathway

In vivo and in vitro experiments were performed to verify the promoting effects of IL-17a administration, IL-17a overexpression, and FAP upregulation in HSCs on liver fibrosis and liver tumorigenesis.